ZA852194B - Immunosuppressant factor - Google Patents

Immunosuppressant factor

Info

Publication number
ZA852194B
ZA852194B ZA852194A ZA852194A ZA852194B ZA 852194 B ZA852194 B ZA 852194B ZA 852194 A ZA852194 A ZA 852194A ZA 852194 A ZA852194 A ZA 852194A ZA 852194 B ZA852194 B ZA 852194B
Authority
ZA
South Africa
Prior art keywords
factor
immunosuppressant
immunosuppressant factor
interleukin
exhibits
Prior art date
Application number
ZA852194A
Other languages
English (en)
Inventor
Adriano Fontana
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP84810140A external-priority patent/EP0155433A1/en
Priority claimed from GB848429679A external-priority patent/GB8429679D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA852194B publication Critical patent/ZA852194B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA852194A 1984-03-23 1985-03-22 Immunosuppressant factor ZA852194B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP84810140A EP0155433A1 (en) 1984-03-23 1984-03-23 Immunosuppressant factor
GB848429679A GB8429679D0 (en) 1984-11-23 1984-11-23 Immunosuppressant factor

Publications (1)

Publication Number Publication Date
ZA852194B true ZA852194B (en) 1986-11-26

Family

ID=26095665

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852194A ZA852194B (en) 1984-03-23 1985-03-22 Immunosuppressant factor

Country Status (12)

Country Link
EP (1) EP0159289B1 (xx)
JP (1) JPH0680080B2 (xx)
AT (1) ATE75778T1 (xx)
AU (1) AU587973B2 (xx)
CA (1) CA1341401C (xx)
DE (1) DE3585968D1 (xx)
DK (1) DK171600B1 (xx)
IE (1) IE58821B1 (xx)
IL (1) IL74680A (xx)
NZ (1) NZ211525A (xx)
WO (1) WO1985004421A1 (xx)
ZA (1) ZA852194B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US6586394B1 (en) 1985-04-19 2003-07-01 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitor
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
JPS63126897A (ja) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd 免疫抑制因子
JPH01501361A (ja) * 1986-11-17 1989-05-18 サンド・アクチエンゲゼルシャフト 新しいｔ細胞サプレッサー因子の生産およびその用途
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
DE68923362T2 (de) * 1988-11-04 1996-03-28 Zuerich Erziehungsdirektion Wachstumsregelfaktoren für neuriten.
WO1998046640A2 (en) * 1997-04-15 1998-10-22 Coulter International Corp. Methods and compositions for inducing immunosuppression
BR9915137A (pt) 1998-11-06 2004-06-08 Martin E Schwab Proteìna, fragmento purificado de uma proteìna, molécula purificada, ácido nucleico, vetor, célula recombinante, métodos de produção de uma proteìna recombinante, de tratamento de um indivìduo com uma doença neoplásica do sistema nervoso central e com dano no sistema nervoso central, de induzir regeneração ou brotação de neurÈnios em um indivìduo, de promoção de plasticidade estrutural do sistema nervoso central de um indivìduo, e, animal não-humano recombinante, método de obtenção de anticorpos policlonais para uma proteìna, amostra de anti-soro isolada, e, método de imunização de um animal não-humano
CA2367132A1 (en) * 1999-03-24 2000-09-28 Gene M. Shearer Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

Also Published As

Publication number Publication date
IE58821B1 (en) 1993-11-17
DK539285D0 (da) 1985-11-21
JPS61501514A (ja) 1986-07-24
AU4157685A (en) 1985-11-01
DK171600B1 (da) 1997-02-17
AU587973B2 (en) 1989-09-07
EP0159289B1 (en) 1992-05-06
DK539285A (da) 1985-11-21
NZ211525A (en) 1991-06-25
JPH0680080B2 (ja) 1994-10-12
IL74680A0 (en) 1985-06-30
ATE75778T1 (de) 1992-05-15
WO1985004421A1 (en) 1985-10-10
EP0159289A1 (en) 1985-10-23
CA1341401C (en) 2002-11-26
IE850732L (en) 1985-09-23
DE3585968D1 (de) 1992-06-11
IL74680A (en) 1988-11-30

Similar Documents

Publication Publication Date Title
IL74680A (en) Immunosuppressant factor derived from human glioblastoma cells
DE3869184D1 (de) Festelektrolyt-brennstoffzelle und zusammenbau.
GB2203138B8 (en) Shaped wood-based active carbon
DE3574579D1 (en) Platte.
NO854182L (no) Feste med flere frihetsgrader.
DE3578806D1 (de) Hueftimplantat.
EP0206424A3 (en) R.f. power amplifier
JPS6460373A (en) Human cells and trioner, antibody and trasformer derived from said cells
IT209301Z2 (it) Protesi uditiva.
GR3017451T3 (en) Peptides having T cell helper activity.
EP0215067A4 (en) Dental braces with adjustable function that can be manufactured in medical practice.
DE3888640D1 (de) Stromregler.
DE3767752D1 (en) Elektrophotographische platte.
EP0216938A4 (en) CATALYST FOR HYDROTREATMENT.
DE68917283D1 (de) Gasdichte Blei-Säure-Batterie.
GR851617B (xx)
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE69102115D1 (de) Bipolare Batterie und Zusammenbau-Methode.
EP0282501A4 (en) REGULATION OF ANIMAL REPRODUCTION.
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
EP0183780A4 (en) DIFFERENTIATION OF HUMAN CELLS.
NO851398L (no) Taakeleggingslegeme.
NO158988C (no) Intraokulaert implantat.
DE3680885D1 (de) 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
DE3877591D1 (en) Aminosaeure-derivate als antihypertensive.